Thorne HealthTech Alpha and Beta Analysis
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Thorne HealthTech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Thorne HealthTech over a specified time horizon. Remember, high Thorne HealthTech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Thorne HealthTech's market risk premium analysis include:
Beta 0.24 | Alpha 0.58 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Thorne |
Thorne HealthTech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Thorne HealthTech market risk premium is the additional return an investor will receive from holding Thorne HealthTech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Thorne HealthTech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Thorne HealthTech's performance over market.| α | 0.58 | β | 0.24 |
Thorne HealthTech Fundamentals Vs Peers
Comparing Thorne HealthTech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Thorne HealthTech's direct or indirect competition across all of the common fundamentals between Thorne HealthTech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Thorne HealthTech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Thorne HealthTech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Thorne HealthTech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Thorne HealthTech to competition |
| Fundamentals | Thorne HealthTech | Peer Average |
| Price To Earning | 100.20 X | 28.72 X |
| Revenue | 228.73 M | 9.43 B |
| EBITDA | 10.31 M | 3.9 B |
| Net Income | 14.93 M | 570.98 M |
| Cash And Equivalents | 27.81 M | 2.7 B |
| Cash Per Share | 0.53 X | 5.01 X |
| Total Debt | 47.03 M | 5.32 B |
Thorne HealthTech Opportunities
Thorne HealthTech Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
About Thorne HealthTech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Thorne or other delisted stocks. Alpha measures the amount that position in Thorne HealthTech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Thorne HealthTech Upcoming Company Events
As portrayed in its financial statements, the presentation of Thorne HealthTech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Thorne HealthTech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Thorne HealthTech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Thorne HealthTech. Please utilize our Beneish M Score to check the likelihood of Thorne HealthTech's management manipulating its earnings.
| 8th of November 2023 Upcoming Quarterly Report | View | |
| 4th of April 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Thorne HealthTech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |